Eosinophilic Esophagitis

Tags

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis

Study title	A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Etrasimod in Adult Subjects With Eosinophilic Esophagitis
Disease or condition	Eosinophilic esophagitis
Study type	Interventional (clinical trial)
Intervention/treatment	Etrasimod (tablet)
Phase	2
Study site	Duke University
Study location	Durham, NC
Principal investigator	David Leiman, MD
Study coordinator name and email	Chris Efird chris.efird@duke.edu
Phone Contact	919-668-5364
Clinicaltrials.gov link	https://clinicaltrials.gov/ct2/show/NCT04682639